{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:34:54Z","timestamp":1757626494059,"version":"3.44.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["UF1NS120871"],"award-info":[{"award-number":["UF1NS120871"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The benefit-risk of statins in patients with lobar intracerebral hemorrhage (ICH) is under investigation in the StATins Use in intRacerebral hemorrhage patieNts (SATURN) trial. The relationship between statin use in ICH survivors, MRI markers of cerebral small vessel disease (CSVD), and outcomes such as recurrent ICH or major adverse cardiovascular or cerebrovascular events (MACCE) is unclear. The ancillary study, SATURN-MRI, intends to evaluate the interrelationship between statin use, the progression of MRI markers of CSVD, and cognitive and functional outcomes. Additionally, SATURN-MRI aims to assess whether baseline MRI markers of CSVD interact with statin continuation for the outcomes of recurrent ICH or MACCE in patients with lobar ICH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A target of 894 SATURN participants will undergo a baseline MRI within 7\u00a0days of randomization and a repeat MRI at the end of the 24-month follow-up period. Any SATURN subject without contraindication to MRI has the option to participate in SATURN MRI. MRIs will be reviewed by blinded central raters to assess for the presence and burden of markers of CSVD and their progression. The primary outcome is new cerebral microbleeds and\/or sulci with cortical superficial siderosis identified on T2*-weighted (GRE, SWI or SWAN) images between baseline and end-study MRI. Additional outcomes include the progression of white matter hyperintensity and incidence of covert infarcts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>The results will provide insights about the interrelationship between the effects of statins, progression of MRI markers of CSVD, and functional and cognitive outcomes. They might lead to the validation of MRI markers as tools to assist with individualized decision-making regarding the effects of statins continuation\/discontinuation in patients with lobar ICH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>ClinicalTrials.gov NCT03936361.\u00a0SATURN Trial was originally registered on May 1, 2019 and modified on February 28, 2022.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13063-025-09024-0","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T12:34:28Z","timestamp":1756557268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SATURN MRI: study protocol for the statin use in intracerebral hemorrhage patients MRI ancillary study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9969-9362","authenticated-orcid":false,"given":"Sarah","family":"Marchina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia D.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon D.","family":"Yeatts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberlee","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Perlmutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth C.","family":"Heistand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph P.","family":"Broderick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios-Arsenios","family":"Lioutas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Marti-Fabregas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdy","family":"Selim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashkan","family":"Shoamanesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"issue":"11","key":"9024_CR1","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1161\/STROKEAHA.120.031471","volume":"52","author":"K Malhotra","year":"2021","unstructured":"Malhotra K, Zompola C, Theodorou A, Katsanos AH, Shoamanesh A, Gupta H, et al. Prevalence, characteristics, and outcomes of undetermined intracerebral hemorrhage: a systematic review and meta-analysis. Stroke. 2021;52(11):3602\u201312.","journal-title":"Stroke"},{"issue":"7","key":"9024_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/14737175.2019.1623671","volume":"19","author":"IC Hostettler","year":"2019","unstructured":"Hostettler IC, Seiffge DJ, Werring DJ. Intracerebral hemorrhage: an update on diagnosis and treatment. Expert Rev Neurother. 2019;19(7):679\u201394.","journal-title":"Expert Rev Neurother"},{"issue":"19","key":"9024_CR3","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1212\/01.wnl.0000435298.80023.7a","volume":"81","author":"A Charidimou","year":"2013","unstructured":"Charidimou A, Peeters AP, Jager R, Fox Z, Vandermeeren Y, Laloux P, et al. Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy. Neurology. 2013;81(19):1666\u201373.","journal-title":"Neurology"},{"issue":"8","key":"9024_CR4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1212\/WNL.0000000000004259","volume":"89","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, Imaizumi T, Moulin S, Biffi A, Samarasekera N, Yakushiji Y, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis. Neurology. 2017;89(8):820\u20139.","journal-title":"Neurology"},{"issue":"7","key":"9024_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/1747493019830065","volume":"14","author":"A Charidimou","year":"2019","unstructured":"Charidimou A, Boulouis G, Roongpiboonsopit D, Xiong L, Pasi M, Schwab KM, et al. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: large prospective cohort and preliminary meta-analysis. Int J Stroke. 2019;14(7):723\u201333.","journal-title":"Int J Stroke"},{"issue":"10","key":"9024_CR6","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1161\/STROKEAHA.112.657486","volume":"43","author":"DC Haussen","year":"2012","unstructured":"Haussen DC, Henninger N, Kumar S, Selim M. Statin use and microbleeds in patients with spontaneous intracerebral hemorrhage. Stroke. 2012;43(10):2677\u201381.","journal-title":"Stroke"},{"issue":"5","key":"9024_CR7","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1161\/STROKEAHA.114.004130","volume":"45","author":"JR Romero","year":"2014","unstructured":"Romero JR, Preis SR, Beiser A, DeCarli C, Viswanathan A, Martinez-Ramirez S, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke. 2014;45(5):1492\u20134.","journal-title":"Stroke"},{"key":"9024_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117224","volume":"420","author":"AH Katsanos","year":"2021","unstructured":"Katsanos AH, Lioutas VA, Charidimou A, Catanese L, Ng KKH, Perera K, et al. Statin treatment and cerebral microbleeds: a systematic review and meta-analysis. J Neurol Sci. 2021;420: 117224.","journal-title":"J Neurol Sci"},{"issue":"6","key":"9024_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/ene.14196","volume":"27","author":"AH Katsanos","year":"2020","unstructured":"Katsanos AH, Lioutas VA, Charidimou A, Catanese L, Ng KKH, Perera K, et al. Statin treatment and accrual of covert cerebral ischaemia on neuroimaging: a systematic review and meta-analysis of randomized trials. Eur J Neurol. 2020;27(6):1023\u20137.","journal-title":"Eur J Neurol"},{"issue":"8","key":"9024_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamaneurol.2016.1017","volume":"73","author":"S Akoudad","year":"2016","unstructured":"Akoudad S, Wolters FJ, Viswanathan A, de Bruijn RF, van der Lugt A, Hofman A, et al. Association of cerebral microbleeds with cognitive decline and dementia. JAMA Neurol. 2016;73(8):934\u201343.","journal-title":"JAMA Neurol"},{"issue":"4","key":"9024_CR11","doi-asserted-by":"publisher","DOI":"10.31083\/j.jin2204082","volume":"22","author":"Y Hou","year":"2023","unstructured":"Hou Y, Yang S, Li Y, Qin W, Yang L, Hu W. Impact of cerebral microbleeds on gait, balance, and upper extremities function in cerebral small vessel disease. J Integr Neurosci. 2023;22(4): 82.","journal-title":"J Integr Neurosci"},{"issue":"3","key":"9024_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt263","volume":"6","author":"S Martinez-Ramirez","year":"2014","unstructured":"Martinez-Ramirez S, Greenberg SM, Viswanathan A. Cerebral microbleeds: overview and implications in cognitive impairment. Alzheimers Res Ther. 2014;6(3): 33.","journal-title":"Alzheimers Res Ther"},{"key":"9024_CR13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/jnnp-2020-323951","volume":"92","author":"L Puy","year":"2021","unstructured":"Puy L, Pasi M, Rodrigues M, van Veluw SJ, Tsivgoulis G, Shoamanesh A, et al. Cerebral microbleeds: from depiction to interpretation. J Neurol Neurosurg Psychiatry. 2021;92:598\u2013607.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9024_CR14","doi-asserted-by":"publisher","unstructured":"Marchina S, Yeatts SD, Foster LD, Janis S, Shoamanesh A, Khatri P, et al. Rationale and Design of the Statins Use in Intracerebral Hemorrhage Patients (SATURN) Trial. Cerebrovasc Dis. 2024.\u00a0https:\/\/doi.org\/10.1159\/000538195.","DOI":"10.1159\/000538195"},{"issue":"8","key":"9024_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822\u201338.","journal-title":"Lancet Neurol"},{"key":"9024_CR16","doi-asserted-by":"publisher","unstructured":"Rankin J. Cerebral vascular accidents in patients over the age of 60. Scott Med J. 1957;2(5):200\u201315. https:\/\/doi.org\/10.1177\/003693305700200504.","DOI":"10.1177\/003693305700200504"},{"key":"9024_CR17","doi-asserted-by":"publisher","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1998;19(5):604\u20137. https:\/\/doi.org\/10.1161\/01.STR.19.5.604.","DOI":"10.1161\/01.STR.19.5.604"},{"key":"9024_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ahj.2016.03.019","volume":"178","author":"MJ O'Donnell","year":"2016","unstructured":"O\u2019Donnell MJ, Eikelboom JW, Yusuf S, Diener HC, Hart RG, Smith EE, et al. Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study. Am Heart J. 2016;178:145\u201350.","journal-title":"Am Heart J"},{"issue":"5","key":"9024_CR19","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1177\/17474930231216339","volume":"19","author":"P Balali","year":"2024","unstructured":"Balali P, Hart RG, Smith EE, Saad F, Colorado P, Lemmens R, et al. Cerebral microbleeds and asundexian in non-cardioembolic ischemic stroke: secondary analyses of the PACIFIC-STROKE randomized trial. Int J Stroke. 2024;19(5):526\u201335.","journal-title":"Int J Stroke"},{"issue":"23","key":"9024_CR20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","volume":"378","author":"RG Hart","year":"2018","unstructured":"Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, et al. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med. 2018;378(23):2191\u2013201.","journal-title":"N Engl J Med"},{"issue":"10107","key":"9024_CR21","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/S0140-6736(17)32252-3","volume":"390","author":"M Dehghan","year":"2017","unstructured":"Dehghan M, Mente A, Zhang X, Swaminathan S, Li W, Mohan V, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet. 2017;390(10107):2050\u201362.","journal-title":"Lancet"},{"issue":"2","key":"9024_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/01.ATV.0000151647.14923.ec","volume":"25","author":"A Undas","year":"2005","unstructured":"Undas A, Brummel-Ziedins KE, Mann KG. Statins and blood coagulation. Arterioscler Thromb Vasc Biol. 2005;25(2):287\u201394.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"9024_CR23","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1161\/01.STR.31.10.2442","volume":"31","author":"U Laufs","year":"2000","unstructured":"Laufs U, Gertz K, Huang P, Nickenig G, Bohm M, Dirnagl U, et al. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke. 2000;31(10):2442\u20139.","journal-title":"Stroke"},{"issue":"6","key":"9024_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/sj.jcbfm.9600070","volume":"25","author":"M Asahi","year":"2005","unstructured":"Asahi M, Huang Z, Thomas S, Yoshimura S, Sumii T, Mori T, et al. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab. 2005;25(6):722\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"9024_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101127","volume":"84","author":"A Sahebkar","year":"2021","unstructured":"Sahebkar A, Kiaie N, Gorabi AM, Mannarino MR, Bianconi V, Jamialahmadi T, et al. A comprehensive review on the lipid and pleiotropic effects of pitavastatin. Prog Lipid Res. 2021;84: 101127.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"9024_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000313614","volume":"30","author":"JH Fu","year":"2010","unstructured":"Fu JH, Mok V, Lam W, Wong A, Chu W, Xiong Y, et al. Effects of statins on progression of subclinical brain infarct. Cerebrovasc Dis. 2010;30(1):51\u20136.","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"9024_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1573403X13666170426104611","volume":"13","author":"E Diamantis","year":"2017","unstructured":"Diamantis E, Kyriakos G, Quiles-Sanchez LV, Farmaki P, Troupis T. The anti-inflammatory effects of statins on coronary artery disease: an updated review of the literature. Curr Cardiol Rev. 2017;13(3):209\u201316.","journal-title":"Curr Cardiol Rev"},{"issue":"3","key":"9024_CR28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s13311-014-0270-5","volume":"11","author":"Y Xiong","year":"2014","unstructured":"Xiong Y, Wong A, Cavalieri M, Schmidt R, Chu WW, Liu X, et al. Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities. Neurotherapeutics. 2014;11(3):606\u201311.","journal-title":"Neurotherapeutics"},{"issue":"12","key":"9024_CR29","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1161\/hs1201.099663","volume":"32","author":"P Sterzer","year":"2001","unstructured":"Sterzer P, Meintzschel F, Rosler A, Lanfermann H, Steinmetz H, Sitzer M. Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease. Stroke. 2001;32(12):2817\u201320.","journal-title":"Stroke"},{"issue":"1","key":"9024_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/01.STR.24.1.49","volume":"24","author":"J Broderick","year":"1993","unstructured":"Broderick J, Brott T, Tomsick T, Leach A. Lobar hemorrhage in the elderly. The undiminishing importance of hypertension. Stroke. 1993;24(1):49\u201351.","journal-title":"Stroke"},{"issue":"4","key":"9024_CR31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1177\/1747493020974464","volume":"16","author":"MG Kozberg","year":"2021","unstructured":"Kozberg MG, Perosa V, Gurol ME, van Veluw SJ. A practical approach to the management of cerebral amyloid angiopathy. Int J Stroke. 2021;16(4):356\u201369.","journal-title":"Int J Stroke"},{"issue":"10","key":"9024_CR32","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1161\/STROKEAHA.107.513176","volume":"39","author":"EJ van Dijk","year":"2008","unstructured":"van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam scan study. Stroke. 2008;39(10):2712\u20139.","journal-title":"Stroke"},{"issue":"8","key":"9024_CR33","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3174\/ajnr.A3108","volume":"33","author":"MM Poels","year":"2012","unstructured":"Poels MM, Ikram MA, Vernooij MW. Improved MR imaging detection of cerebral microbleeds more accurately identifies persons with vasculopathy. AJNR Am J Neuroradiol. 2012;33(8):1553\u20136.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"9024_CR34","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1161\/STROKEAHA.118.023368","volume":"50","author":"A Charidimou","year":"2019","unstructured":"Charidimou A, Boulouis G, Xiong L, Pasi M, Roongpiboonsopit D, Ayres A, et al. Cortical superficial siderosis evolution. Stroke. 2019;50(4):954\u201362.","journal-title":"Stroke"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09024-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09024-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09024-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:41:25Z","timestamp":1757457685000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09024-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9024"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09024-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2025,8,30]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study protocol is reviewed and approved by the StrokeNet institutional review board at the University of Cincinnati (Number 2018-6381C).\u00a0Written informed consent will be obtained from all participants or their legally authorized representative.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}